Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson’s disease: the ADepT-PD RCT pilot

Background There is insufficient evidence on the effectiveness of different antidepressants in Parkinson’s disease. This trial was commissioned to provide robust evidence regarding the effectiveness of a tricyclic and a selective serotonin reuptake inhibitor on depression in people with Parkinson’s...

Description complète

Détails bibliographiques

Auteurs principaux:	Anette Schrag, Camille Carroll, Glyn Lewis, Marc Serfaty, Gordon Duncan, Sophie Molloy, John Whipps, Blair McLennan, Jing Yi (Jessica) Weng, Rachael M Hunter, Caroline S Clarke, Nicholas Freemantle, Andrew Embleton-Thirsk
Format:	Artigo
Langue:	Inglês
Publié:	NIHR Journals Library 2025-11-01
Collection:	Health Technology Assessment
Sujets:	parkinson’s disease depression randomised controlled trial escitalopram nortriptyline placebo
Accès en ligne:	https://doi.org/10.3310/HFDO7575
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!